Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AFME.PA Stock Summary
Top 10 Correlated ETFs
AFME.PA
In the News
AFME.PA Financial details
Company Rating
Neutral
Market Cap
58.94M
Income
-22.52M
Revenue
1.22M
Book val./share
1.43
Cash/share
0.24
Dividend
-
Dividend %
-
Employees
52
Optionable
No
Shortable
Yes
Earnings
28 Sep 2023
P/E
-2.11
Forward P/E
-3.3
PEG
3.71
P/S
-
P/B
0.95
P/C
7.29
P/FCF
-4.68
Quick Ratio
0.3
Current Ratio
0.83
Debt / Equity
0.45
LT Debt / Equity
0.4
-
-
EPS (TTM)
-0.83
EPS next Y
-0.53
EPS next Q
-
EPS this Y
-7.95%
EPS next Y
-36.14%
EPS next 5Y
-277.11%
EPS last 5Y
2.38%
Revenue last 5Y
98.91%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
32.33%
SMA50
3.53%
SMA100
45.45%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-39%
ROC
-0.28%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
33.15M
Shs Float
19.52M
-
-
-
-
Target Price
-
52W Range
0.93-2.3
52W High
-
52W Low
-
RSI
55.43
Rel Volume
0.79
Avg Volume
11.13K
Volume
8.8K
Perf Week
-2.78%
Perf Month
20.69%
Perf Quarter
68.27%
Perf Half Y
56.25%
-
-
-
-
Beta
0.396
-
-
Volatility
0.03%, 0.2%
Prev Close
2.34%
Price
1.75
Change
1.74%
AFME.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2017-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.08 | 0.07 | 0.09 | 0.07 | |
Net income per share | -0.74 | -0.89 | -1.18 | -0.88 | -0.81 | |
Operating cash flow per share | -0.91 | -0.66 | -0.73 | -0.73 | -0.59 | |
Free cash flow per share | -0.93 | -0.67 | -0.76 | -0.75 | -0.6 | |
Cash per share | 0.41 | 0.11 | 0.46 | 0.67 | 0.14 | |
Book value per share | 5.16 | 1.67 | 2.9 | 2.59 | 1.8 | |
Tangible book value per share | 0.32 | -3.11 | -1.6 | -0.56 | -0.91 | |
Share holders equity per share | 5.16 | 1.67 | 2.9 | 2.59 | 1.8 | |
Interest debt per share | 0.25 | 1.36 | 1.88 | 1.35 | 1 | |
Market cap | 95.2M | 148.74M | 97.44M | 95.82M | 31.58M | |
Enterprise value | 93.17M | 170.79M | 112.57M | 104.17M | 46.74M | |
P/E ratio | -10.88 | -8.97 | -6.81 | -6.47 | -2.07 | |
Price to sales ratio | 2.21K | 104.08 | 118.26 | 66.04 | 23.59 | |
POCF ratio | -8.78 | -12.2 | -10.9 | -7.75 | -2.85 | |
PFCF ratio | -8.57 | -12.01 | -10.55 | -7.55 | -2.81 | |
P/B Ratio | 1.55 | 4.8 | 2.76 | 2.2 | 0.93 | |
PTB ratio | 1.55 | 4.8 | 2.76 | 2.2 | 0.93 | |
EV to sales | 2.17K | 119.52 | 136.62 | 71.79 | 34.9 | |
Enterprise value over EBITDA | -9.32 | -13.11 | -10.73 | -9.61 | -3.96 | |
EV to operating cash flow | -8.59 | -14.01 | -12.6 | -8.42 | -4.22 | |
EV to free cash flow | -8.39 | -13.79 | -12.18 | -8.2 | -4.16 | |
Earnings yield | -0.09 | -0.11 | -0.15 | -0.15 | -0.48 | |
Free cash flow yield | -0.12 | -0.08 | -0.09 | -0.13 | -0.36 | |
Debt to equity | 0.05 | 0.75 | 0.59 | 0.45 | 0.52 | |
Debt to assets | 0.04 | 0.36 | 0.32 | 0.28 | 0.3 | |
Net debt to EBITDA | 0.2 | -1.69 | -1.44 | -0.77 | -1.28 | |
Current ratio | 3.75 | 0.64 | 0.81 | 2.01 | 0.83 | |
Interest coverage | -62.02 | -8.11 | -5.82 | -4.33 | -13.23 | |
Income quality | 1.24 | 0.73 | 0.62 | 0.83 | 0.73 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 56.49 | 9.06 | 4.04 | 3.58 | 3.86 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.02 | 0.04 | |
Intangibles to total assets | 0.85 | 1.36 | 0.84 | 0.76 | 0.85 | |
Capex to operating cash flow | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 | |
Capex to revenue | -6.12 | -0.14 | -0.37 | -0.23 | -0.11 | |
Capex to depreciation | -0.75 | -0.09 | -0.12 | -0.14 | -0.06 | |
Stock based compensation to revenue | 0 | 0.31 | 1.16 | 0.03 | 0.11 | |
Graham number | 9.24 | 5.78 | 8.75 | 7.15 | 5.73 | |
ROIC | -0.13 | -0.26 | -0.22 | -0.2 | -0.27 | |
Return on tangible assets | -0.89 | 0.7 | -1.42 | -0.86 | -1.69 | |
Graham Net | -0.09 | -1.58 | -1.83 | -0.77 | -1.1 | |
Working capital | 7.02M | -3.39M | -1.85M | 7.37M | -1.46M | |
Tangible asset value | 3.85M | -57.88M | -19.48M | -9.36M | -17.19M | |
Net current asset value | 3.57M | -28.17M | -21.63M | -11.83M | -19.01M | |
Invested capital | 0.05 | 0.75 | 0.59 | 0.45 | 0.52 | |
Average receivables | 0 | 0 | 2.79M | 2.43M | 3.47M | |
Average payables | 1.9M | 0 | 3.03M | 2.07M | 2.41M | |
Average inventory | 0 | 0 | 145K | 145K | 0 | |
Days sales outstanding | 0 | 919.27 | 873.52 | 727.74 | 1.1K | |
Days payables outstanding | 124.37 | 598.21 | 276.22 | 259.91 | 451.21 | |
Days of inventory on hand | 0 | 0 | 34.06 | 0 | 0 | |
Receivables turnover | 0 | 0.4 | 0.42 | 0.5 | 0.33 | |
Payables turnover | 2.93 | 0.61 | 1.32 | 1.4 | 0.81 | |
Inventory turnover | 0 | 0 | 10.72 | 0 | 0 | |
ROE | -0.14 | -0.54 | -0.41 | -0.34 | -0.45 | |
Capex per share | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.02 | 0.02 | 0 | 0.01 | |
Net income per share | 0 | -0.18 | -0.36 | 0 | -0.29 | |
Operating cash flow per share | 0 | -0.12 | -0.24 | 0 | -0.31 | |
Free cash flow per share | 0 | -0.12 | -0.24 | 0 | -0.32 | |
Cash per share | 0 | 0.13 | 0.13 | 0 | 0.24 | |
Book value per share | 0 | 1.75 | 1.71 | 0 | 1.43 | |
Tangible book value per share | 0 | -0.89 | -0.87 | 0 | -0.41 | |
Share holders equity per share | 0 | 1.75 | 1.71 | 0 | 1.43 | |
Interest debt per share | 0 | 0.77 | 0.91 | 0 | 0.67 | |
Market cap | 0 | 42.6M | 33.27M | 0 | 33.79M | |
Enterprise value | 15.39M | 40.02M | 48.43M | 2.58M | 44.79M | |
P/E ratio | 0 | -3.03 | -1.18 | 0 | -1.06 | |
Price to sales ratio | 0 | 134.38 | 104.96 | 0 | 114.56 | |
POCF ratio | 0 | -18.4 | -7.04 | 0 | -3.95 | |
PFCF ratio | 0 | -18.07 | -6.91 | 0 | -3.93 | |
P/B Ratio | 0 | 1.26 | 0.98 | 0 | 0.87 | |
PTB ratio | 0 | 1.26 | 0.98 | 0 | 0.87 | |
EV to sales | 0 | 126.24 | 152.76 | 8.75 | 151.83 | |
Enterprise value over EBITDA | 0 | -13.54 | -7.59 | -0.83 | -6.48 | |
EV to operating cash flow | 0 | -17.29 | -10.24 | -0.6 | -5.23 | |
EV to free cash flow | 0 | -16.98 | -10.06 | -0.6 | -5.21 | |
Earnings yield | 0 | -0.08 | -0.21 | 0 | -0.24 | |
Free cash flow yield | 0 | -0.06 | -0.14 | 0 | -0.25 | |
Debt to equity | 0.53 | 0.44 | 0.52 | 0 | 0.45 | |
Debt to assets | 0.3 | 0.25 | 0.3 | 0 | 0.28 | |
Net debt to EBITDA | 0 | 0.87 | -2.37 | -0.83 | -1.59 | |
Current ratio | 1 | 0.83 | 0.83 | 0 | 1.65 | |
Interest coverage | 0 | 0 | -38.4 | 0 | -11.83 | |
Income quality | 0 | 0.66 | 0.67 | 1.07 | 1.07 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.03 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 8.26 | 19.92 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.84 | 0.85 | 0.85 | 0 | 0.79 | |
Capex to operating cash flow | 0 | 0.02 | 0.02 | 0 | 0 | |
Capex to revenue | 0 | -0.13 | -0.26 | 0 | -0.12 | |
Capex to depreciation | 0 | -0.07 | -0.07 | 0 | -0.03 | |
Stock based compensation to revenue | 0 | -0.31 | -0.31 | 0 | 0 | |
Graham number | 0 | 2.67 | 3.7 | 0 | 3.07 | |
ROIC | 0 | -0.07 | -0.13 | -0.11 | -0.13 | |
Return on tangible assets | 0 | -0.39 | -0.78 | 0 | -0.59 | |
Graham Net | 0 | -1.22 | -1.04 | 0 | -0.54 | |
Working capital | -34K | -1.46M | -1.46M | 2.58M | 4.68M | |
Tangible asset value | -16.55M | -17.19M | -17.19M | 0 | -11.14M | |
Net current asset value | -18.71M | -19.01M | -19.01M | 2.58M | -12.73M | |
Invested capital | 0.53 | 0.44 | 0.52 | 0 | 0.45 | |
Average receivables | 0 | 0 | 2.02M | 2.02M | 2.28M | |
Average payables | 0 | 2.55M | 3.02M | 1.51M | 918K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 1.15K | 0 | 1.39K | |
Days payables outstanding | 0 | 515.75 | 222.97 | 0 | 137.01 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0.08 | 0 | 0.06 | |
Payables turnover | 0 | 0.17 | 0.4 | 0 | 0.66 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.1 | -0.21 | -0.12 | -0.2 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
AFME.PA Frequently Asked Questions
What is Affluent Medical SA stock symbol ?
Affluent Medical SA is a FR stock and trading under the symbol AFME.PA
What is Affluent Medical SA stock quote today ?
Affluent Medical SA stock price is $1.75 today.
Is Affluent Medical SA stock public?
Yes, Affluent Medical SA is a publicly traded company.